Public Profile

Chengdu Kanghong Pharmaceutical Group Co., Ltd

Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in the development and production of innovative medical products, particularly in the fields of ophthalmology and oncology. Kanghong's core offerings include a range of high-quality pharmaceuticals and medical devices, distinguished by their commitment to research and development. The company has achieved notable market recognition, positioning itself as a trusted provider in both domestic and international markets. With a focus on enhancing patient care, Kanghong continues to expand its operational footprint, contributing to advancements in healthcare solutions.

DitchCarbon Score

How does Chengdu Kanghong Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Chengdu Kanghong Pharmaceutical Group Co., Ltd's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

Chengdu Kanghong Pharmaceutical Group Co., Ltd's reported carbon emissions

Chengdu Kanghong Pharmaceutical Group Co., Ltd, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the absence of concrete emissions data, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and climate commitments. Companies in this sector are often encouraged to adopt science-based targets and implement strategies to reduce their carbon footprint. Chengdu Kanghong Pharmaceutical Group may be aligning with these industry trends, but specific commitments or initiatives have not been disclosed at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chengdu Kanghong Pharmaceutical Group Co., Ltd's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Chengdu Kanghong Pharmaceutical Group Co., Ltd is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chengdu Kanghong Pharmaceutical Group Co., Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Novartis

CH
Research and development services (73)
Updated 3 days ago

Alimera Sciences, Inc.

US
Chemicals nec
Updated 5 days ago
DitchCarbon Score

Genentech

US
Research and development services (73)
Updated 2 days ago

Allergan

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers